LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

TD Asset Management Inc's Holding History (CIK: 0001056053)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 1,004,642 Value ($000) $540 Avg Close — Range —
Q4 2024
Shares 1,004,642 Value ($000) $643 Avg Close — Range —
Q3 2024
Shares 1,004,642 Value ($000) $1,517 Avg Close — Range —
Q2 2024
Shares 1,004,642 Value ($000) $1,457 Avg Close — Range —
Q1 2024
Shares 963,842 Value ($000) $2,149 Avg Close — Range —
Q4 2023
Shares 916,232 Value ($000) $1,777 Avg Close — Range —
Q3 2023
Shares 916,232 Value ($000) $1,347 Avg Close — Range —
Q2 2023
Shares 431,916 Value ($000) $1,373 Avg Close — Range —
Q1 2023
Shares 179,689 Value ($000) $424 Avg Close — Range —
Q4 2022
Shares 179,689 Value ($000) $624 Avg Close — Range —
Q3 2022
Shares 179,689 Value ($000) $1,331 Avg Close — Range —
Q2 2022
Shares 179,689 Value ($000) $1,172 Avg Close — Range —
Q1 2022
Shares 179,689 Value ($000) $907 Avg Close — Range —
Q4 2021
Shares 168,689 Value ($000) $1,306 Avg Close — Range —
Q3 2021
Shares 112,640 Value ($000) $1,667 Avg Close — Range —
Q2 2021
Shares 86,489 Value ($000) $1,254 Avg Close — Range —